IMP
Process View
disruption of cells of other organism involved in symbiotic interaction
A process in which an organism has a negative effect on the functioning of the second organism's cells, where the two organisms are in a symbiotic interaction.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "disruption of cells of other organism involved in symbiotic interaction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| IL8 | interleukin 8 | 0.912 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.539 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.531 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.414 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.316 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.184 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.169 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.164 | ||
| BAX | BCL2-associated X protein | 0.120 | ||
| PRKCD | protein kinase C, delta | 0.114 | ||
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.110 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.106 | Mouse | |
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.077 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.057 | ||
| TRIM9 | tripartite motif containing 9 | 0.046 | ||
| FGA | fibrinogen alpha chain | 0.045 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.040 | ||
| APOA2 | apolipoprotein A-II | 0.039 | ||
| BCL2A1 | BCL2-related protein A1 | 0.033 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.032 | ||
| CAV2 | caveolin 2 | 0.030 | ||
| INADL | InaD-like (Drosophila) | 0.023 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.023 | ||
| PTX3 | pentraxin 3, long | 0.020 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.020 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.020 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.019 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.019 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.019 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.018 | ||
| MPO | myeloperoxidase | 0.017 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.017 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.017 | ||
| PRKCA | protein kinase C, alpha | 0.016 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.016 | ||
| FAM75A7 | family with sequence similarity 75, member A7 | 0.016 | ||
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.016 | ||
| HPX | hemopexin | 0.015 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.015 | ||
| PASK | PAS domain containing serine/threonine kinase | 0.014 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.014 | ||
| LCN2 | lipocalin 2 | 0.014 | ||
| APOC3 | apolipoprotein C-III | 0.014 | ||
| OR2T6 | olfactory receptor, family 2, subfamily T, member 6 | 0.014 | ||
| S100A9 | S100 calcium binding protein A9 | 0.014 | ||
| HP | haptoglobin | 0.014 | ||
| FPR1 | formyl peptide receptor 1 | 0.013 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.013 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.013 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.013 | ||
| G0S2 | G0/G1switch 2 | 0.012 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.012 | ||
| S100A12 | S100 calcium binding protein A12 | 0.012 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.012 | ||
| AZU1 | azurocidin 1 | 0.012 | ||
| PROCR | protein C receptor, endothelial | 0.012 | ||
| BPI | bactericidal/permeability-increasing protein | 0.012 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.011 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.011 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.011 | ||
| CFB | complement factor B | 0.011 | ||
| S100P | S100 calcium binding protein P | 0.011 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| PF4V1 | platelet factor 4 variant 1 | 0.011 | ||
| LTF | lactotransferrin | 0.011 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.011 | ||
| NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.010 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.010 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.010 | ||
| SDPR | serum deprivation response | 0.010 |